As hearings kick off in Apotex v USA arbitration, new pleadings show continued sparring over Canadian drug companies’ claim to own NAFTA-protected investments

You are not logged in. If you are a subscriber, please Login to access. If you are not a subscriber, you can contact us for a rate quote at Alternatively, you can sign up to receive free email headlines here.